Dr. William Dowd Joins Akermin Scientific Advisory Board

 

FOR IMMEDIATE RELEASE

CONTACT:

Rich Zvosec

Office: (314) 821-8140

Mobile: (952) 270-3118

 

Brings Expertise in Bioprocessing and Polymer Science

 

St. Louis, MO - Dr. William Dowd, whose career in chemicals and biotechnology spanned 30 years at Dow Chemical Company, has joined Akermin’s Scientific Advisory Board.  Dr. Dowd had been Global R&D Director for Industrial Biotechnology at Dow Chemical when he retired in 2000.

While at Dow he had responsibility for technology development in all of Dow’s industrial biotechnology activities. Over his tenure, he also held a wide range of process research and corporate R&D positions including Director, Materials R&D laboratory and Platform Leader, Biomaterials.  He was formerly a member of the Board of Directors of Neoprobe Corporation and the Biotechnology Research and Development Corporation, as well as the Scientific Advisory Board of zuChem.  He currently consults with several early stage bio-based materials companies.  Dr. Dowd received his Ph.D. in 1970 in Physical-Organic Chemistry from Indiana University.

“Bill brings a wealth of experience and knowledge to Akermin’s development activities for the commercialization of our proprietary enzyme stabilization technologies,” said Barry Blackwell, President and CEO of Akermin.  “His insight and guidance will be an invaluable resource as we advance our technology.”
About Akermin, Inc.

 

About Akermin, Inc.

Akermin, located in Saint Louis, MO, is a leading developer of stabilized enzyme solutions for producing power, food, fuels, and specialty chemical intermediates.  Through our unique Stabilized Enzyme Biocatalysis System (SEBS^TM), we enable new biocatalytic processes and make existing enzymatic transformations more robust and efficient under a wide range of operating conditions, including extremes of temperature and pH.  Akermin's proprietary breakthrough in the polymer encapsulation of enzymes will lead to longer-lasting and more environmentally-friendly fuel cells and batteries, and enhance the value of food, pharmaceutical and chemical production.  SEBS^TM has demonstrated the capability to immobilize numerous enzymes and proven the potential for Akermin's technology in multi-billion dollar markets for enzyme-enabled products and processes.